Scarica l'app Stockscreener
3.02
6.21%
-0.20
Pre-mercato:
3.23
0.21
+6.95%
Precedente Chiudi:
$3.22
Aprire:
$3.19
Volume 24 ore:
69,154
Relative Volume:
0.77
Capitalizzazione di mercato:
$26.28M
Reddito:
-
Utile/perdita netta:
$-4.08M
Rapporto P/E:
-2.5682
EPS:
-1.1759
Flusso di cassa netto:
$-2.58M
1 W Prestazione:
-22.76%
1M Prestazione:
-20.11%
6M Prestazione:
-31.05%
1 anno Prestazione:
+20.32%
Intervallo 1D:
$2.94
$3.27
Intervallo di 1 settimana:
$2.94
$3.95
Portata 52W:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Nome
Lixte Biotechnology Holdings Inc
Settore
Industria
Telefono
310 203 2902
Indirizzo
433 PLAZA REAL, BOCA RATON
Compare LIXT vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.02 | 28.02M | 0 | -4.08M | -2.58M | -1.1759 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.81 | 119.38B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.63 | 81.46B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
820.31 | 52.65B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.24 | 46.50B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
347.00 | 38.95B | 4.98B | 69.60M | 525.67M | 0.5198 |
Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie
Improving the Odds: How LIXTE Biotechnology (LIXT) Is Working to Make Cancer Therapies More Effective - NewMediaWire
Improving the Odds: How LIXTE Biotechnology (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective - Digital Journal
Earnings Miss: Is Lixte Biotechnology Holdings Inc stock forming a triangle pattern2025 Retail Activity & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Market Overview: What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock attractive todayJuly 2025 Breakouts & Safe Capital Growth Plans - baoquankhu1.vn
Retail Trends: Is Lixte Biotechnology Holdings Inc a stock for growth or value investors2025 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
LIXTE Biotechnology Holdings (LIXT) Advances a Novel Approach to Enhancing Cancer Therapy - NewMediaWire
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event - The Globe and Mail
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy - Digital Journal
Datavault AI (NASDAQ: DVLT) Closes Acquisition of API Media Innovation - financial-news.co.uk
De La Soul Set to Lead Good Health Summit at Morehouse College - EBONY Magazine
Stop Loss: Can C3is Inc weather a recessionEarnings Overview Summary & Safe Capital Growth Plans - baoquankhu1.vn
LIXTE Biotechnology Advances Novel Cancer Therapy Approach Targeting PP2A Enzyme - citybuzz -
Spartan Capital Securities, LLC Proudly Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering - Big News Network.com
Highs Report: What makes Lixte Biotechnology Holdings Inc Equity Warrant stock attractive today2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn
Is Lixte Biotechnology Holdings Inc stock a value trapFed Meeting & AI Forecasted Entry and Exit Points - baoquankhu1.vn
LIXTE Biotechnology Holdings (LIXT) Sponsors Good Health Mind, Body and Soul Summit - Yahoo Finance
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit - Digital Journal
LIXTE Biotechnology Sponsors Health Equity Summit at Morehouse College, Linking Cancer Research to Community Wellness - citybuzz -
De La Soul's 'Good Health' summit targets Black men's wellness - Stock Titan
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE - The Globe and Mail
Lixte Biotechnology to Present at DealFlow Discovery Conference as Clinical Trials Advance - citybuzz -
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29 - manilatimes.net
How Lixte Biotechnology Holdings Inc. stock compares to growth peersSector Performance Review & Rapid Portfolio Trading - Bollywood Helpline
Is Lixte Biotechnology Holdings Inc. a stock for growth or value investorsQuarterly Earnings Summary & Real-Time Volume Trigger Notifications - bollywoodhelpline.com
Breakout Move: Can Arvinas Inc grow without external fundingJuly 2025 Spike Watch & Precise Buy Zone Identification - baoquankhu1.vn
Aug Movers: Is OPAD a play on infrastructure spending2025 Trade Ideas & Expert Approved Trade Ideas - baoquankhu1.vn
Pullback Watch: Whats the profit margin of Lixte Biotechnology Holdings IncJuly 2025 Action & Growth Oriented Trading Recommendations - baoquankhu1.vn
Institution Moves: How Lixte Biotechnology Holdings Inc stock performs after earningsJuly 2025 Market Mood & Low Volatility Stock Suggestions - Bộ Nội Vụ
LIXTE Biotechnology Engages IBN to Amplify Communications for Cancer Therapy Development - citybuzz -
About Us - FinancialContent
LIXTE Biotechnology (LIXT) Enhances Visibility with New Communications Strategy - GuruFocus
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc. - The Manila Times
Breakout Zone: Can Lixte Biotechnology Holdings Inc Equity Warrant withstand a market correctionPortfolio Gains Summary & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Weekly Trades: How Lixte Biotechnology Holdings Inc stock compares to growth peersEarnings Performance Report & Real-Time Buy Signal Notifications - Bộ Nội Vụ
Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuationTreasury Yields & Expert-Curated Trade Recommendations - ulpravda.ru
Will Lixte Biotechnology Holdings Inc. stock see insider buyingTake Profit & Smart Swing Trading Techniques - Улправда
Is Lixte Biotechnology Holdings Inc. stock a buy before product launchesPortfolio Return Summary & Entry and Exit Point Strategies - ulpravda.ru
Should I hold or sell Lixte Biotechnology Holdings Inc. stock in 2025Weekly Investment Summary & Accurate Technical Buy Alerts - Улправда
Can Lixte Biotechnology Holdings Inc. (8640) stock ride next bull market cycleQuarterly Market Review & Technical Buy Zone Confirmation - Улправда
LIXTE Biotechnology Holdings (LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - NewMediaWire
Will Lixte Biotechnology Holdings Inc. (8640) stock beat revenue estimatesFed Meeting & Low Risk Entry Point Tips - Улправда
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Lixte Biotechnology Expands Ovarian Cancer Trial with MD Anderson and GSK - citybuzz -
Will Lixte Biotechnology Holdings Inc. stock benefit from infrastructure spending2025 Volume Leaders & AI Driven Stock Reports - ulpravda.ru
Lixte Biotechnology files to sell 5.26M shares of common stock, warrants - MSN
How strong is Lixte Biotechnology Holdings Inc. Equity Warrant stock revenue growth2025 Trade Ideas & Entry Point Strategy Guides - Улправда
Lixte Biotechnology announces new registered direct offering - MSN
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - financial-news.co.uk
Breakout Zone: Why Lixte Biotechnology Holdings Inc. stock is a value investor pickJuly 2025 Weekly Recap & Real-Time Market Sentiment Reports - Улправда
Can Lixte Biotechnology Holdings Inc. stock continue upward trendEarnings Forecast Updates & High Yield Trading Growth - ulpravda.ru
Lixte Biotechnology Holdings Inc Azioni (LIXT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
2.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):